SMMT NASDAQ
Summit Therapeutics Inc.
1W: +7.4%
1M: +14.8%
3M: +5.2%
YTD: -4.3%
1Y: -18.2%
3Y: +772.9%
5Y: +221.1%
$16.75
+0.07 (+0.39%)
Weekly Expected Move ±7.4%
$14
$16
$17
$18
$19
Overview
News
Chart
Smart Money
Financials
Income Statement
Cash Flow
Balance Sheet
Earnings
Dividends
Analysis
Technicals
Weather
Peers
ESG
Institutions
ETF Exposure
Dark Pool
Short Interest
Supply Chain
📊 Key Metrics
TTM$0M
Revenue
+0.0% YoY
$-856M
Net Income
-14.7% YoY
$-433M
Free Cash Flow
-108.6% YoY
0.0%
Gross Margin
0.0%
Op. Margin
0.0%
Net Margin
💰 Income Flow
How revenue becomes profit💵 Cash Flow
⚠️ Cash Burn Where cash goes🏦 Balance Sheet
Assets = Liabilities + Equity📈 Financial Health
Profitability
ROE-192.5%
ROA-159.1%
ROIC1714.4%
Valuation
P/E-15.0
P/B20.7
EV/EBITDA-12.5
Leverage
Debt/Equity0.03
Current Ratio6.96
Interest Cov.0.0x
Quality Scores
Piotroski F3/9
Altman Z47.87
Beneish M0.00